(Uludağ Üniversitesi Tıp Fakültesi Radyasyon Onkolojisi Anabilim Dalı, Bursa, Türkiye)
Ahmet Sami BAYRAM
(Uludağ Üniversitesi Tıp Fakültesi Göğüs Cerrahisi Anabilim Dalı, İstanbul, Türkiye)
Hüseyin MELEK
(Uludağ Üniversitesi Tıp Fakültesi Göğüs Cerrahisi Anabilim Dalı, İstanbul, Türkiye)
(Uludağ Üniversitesi Tıp Fakültesi Göğüs Cerrahisi Anabilim Dalı, İstanbul, Türkiye)
Yıl: 2020Cilt: 35Sayı: 2ISSN: 1300-7467Sayfa Aralığı: 167 - 177İngilizce

67 0
Radiotherapy in Patients with Trachea Tumours: A Retrospective Study and Literature Review
OBJECTIVE In this study, we aimed to evaluate our patients with tracheal tumours treated with primary or adjuvant radiotherapy (RT) and to review the current literature on the subject. METHODS Between 1998 and 2017, eight patients underwent RT. Their median age was 37 years (15–53). The diagnosis was adenoid cystic carcinoma in five patients, squamous cell carcinoma in three patients and mucoepidermoid carcinoma in one patient. Resection type was R0 (1), R1 (4), R2 (1), and biopsy (2). The median tumour size was 2.6 cm (2–5). Median 59.4 Gy RT (32.4–66.6) was given, and weekly cisplatin was administered to four patients concomitantly. RESULTS With a median follow-up of 85 months (4–189), five patients were alive. The 5-year overall and diseasefree survival rates were 83% and 67%, respectively. There was no local recurrence in any patient. In one patient who had a complete response with curative chemo-RT, dilatation was performed five times in 10 years because tracheal stenosis developed at 60 months. CONCLUSION Trachea tumours are rare, and the primary treatment is surgery. Adjuvant RT is controversial in R0 cases. In unresectable cases, RT is the primary treatment modality. We believe that our treatment results will contribute to the literature on the subject.
DergiAraştırma MakalesiErişime Açık
  • 1. Gomez DR, Fuller CD, Chennupati S, Thomas Jr CR. Mediastinal and Tracheal Cancer. In: Halperin EC, Wazer DE, Perez CA, Brady LW editors. Perez and Bradys Principles and Practice of Radiation Oncology. 6th edition, Philadelphia: LWW; 2013. p. 973–95.
  • 2. Bhattacharyya N. Contemporary staging and prognosis for primary tracheal malignancies: a population-based analysis. Otolaryngol Head Neck Surg 2004;131(5):639–42.
  • 3. Licht PB, Friis S, Pettersson G. Tracheal cancer in Denmark: a nationwide study. Eur J Cardiothorac Surg 2001;19(3):339–45.
  • 4. Mallick S, Benson R, Giridhar P, Rajan Singh A, Rath GK. Demography, patterns of care and survival outcomes in patients with malignant tumors of trachea: A systematic review and individual patient data analysis of 733 patients. Lung Cancer 2019;132:87–93.
  • 5. Grillo HC, Mathisen DJ. Primary tracheal tumors: Treatment and results. Ann Thorac Surg 1990;49(1):69–77.
  • 6. Macchiarini P. Primary tracheal tumours. Lancet Oncol 2006;7(1):83–91.
  • 7. Webb BD, Walsh GL, Roberts DB, Sturgis EM. Primary tracheal malignant neoplasms: The University of Texas MD Anderson Cancer Center Experience. J Am Coll Surg 2006;202(2):237–46.
  • 8. He J, Shen J, Huang J, Dai C, Liang W, Ye M, et al. Prognosis of primary tracheal tumor: A populationbased analysis. J Surg Oncol 2017;115(8):1004–10.
  • 9. Honings J, Gaissert HA, Verhagen AF, van Dijck JA, van der Heijden HF, van Die L, et al. Undertreatment of tracheal carcinoma: multidisciplinary audit of epidemiologic data. Ann Surg Oncol 2009;16(2):246–53.
  • 10. Gaissert HA, Grillo HC, Shadmehr MB, Wright CD, Gokhale M, Wain JC, et al. Long-term survival after resection of primary ACC and SCC of the trachea and carina. Ann Thorac Surg 2004;78(6):1889–96.
  • 11. Yang KY, Chen YM, Huang MH, Perng RP. Revisit of primary malignant neoplasma of the trachea: clinical characteristics and survival analysis. Jpn J Clin Oncol 1997;27(5):305–9.
  • 12. Regnard JF, Fourquier P, Levasseur P. Results and prognostic factors in resections of primary tracheal tumors: a multicenter retrospective study. The French Society of Cardiovascular Surgery. J Thorac Cardiovasc Surg 1996;111(4):808–13.
  • 13. National Cancer Institue. DCTD Division of Cancer Treatment and Diagnosis. Available at: https://ctep. cancer.gov/. Accessed Feb 20, 2020.
  • 14. Honings J, Gaissert HA, Weinberg AC, Mark EJ, Wright CD, Wain JC, et al. Prognostic value of pathologic characteristics and resection margins in tracheal adenoid cystic carcinoma. Eur J Cardiothorac Surg 2010;37(6):1438–44.
  • 15. Urdaneta AI, Yu JB, Wilson LD. Population based cancer registry analysis of primary tracheal carcinoma. Am J Clin Oncol 2011;34(1):32–7.
  • 16. Xie L, Fan M, Sheets NC, Chen RC, Jiang GL, Marks LB. The use of radiation therapy appears to improve outcome in patients with malignant primary tracheal tumors: a SEER-based analysis. Int J Radiat Oncol Biol Phys 2012;84(2):464–70.
  • 17. Wen J, Liu D, Xu X, Chen D, Chen Y, Sun L, et al. Nomograms for predicting survival outcomes in patients with primary tracheal tumors: a large populationbased analysis. Cancer Manag Res 2018;10:6843–56.
  • 18. Yusuf M, Gaskins J, Trawick E, Tennant P, Bumpous J, van Berkel V, et al. Effects of adjuvant radiation therapy on survival for patients with resected primary tracheal carcinoma: an analysis of the National Cancer Database. Jpn J Clin Oncol. 2019 Jul 1;49(7):628–38.
  • 19. Levy A, Omeiri A, Fadel E, Le Péchoux C. Radiotherapy for tracheal-bronchial cystic adenoid carcinomas. Clin Oncol (R Coll Radiol) 2018;30(1):39–46.
  • 20. Song Z, Liu Z, Wang J, Zhu H, Zhang Y. Primary tracheobronchial mucoepidermoid carcinoma – a retrospexctive study of 32 patients. World J Surg Oncol 2013;11:62.
  • 21. Honings J, Gaissert HA, Ruangchira-Urai R, Wain JC, Wright CD, Mathisen DJ, et al. Pathologic characteristics of resected squamous cell carcinoma of the trachea: prognostic factors based on an analysis of 59 cases. Virchows Arch 2009;455(5):423–9.
  • 22. Napieralska A, Miszczyk L, Blamek S.Tracheal cancer- treatment results, prognostic factors and incidence of other neoplasms. Radiol Oncol 2016;50(4):409–17.
  • 23. Chow DC, Komaki R, Libshitz HI, Mountain CF, Ellerbroek N. Treatment of primary neoplasms of the trachea. The role of radiotherapy. Cancer 1993;71(10):2946–52.
  • 24. Maziak DE, Todd TR, Keshavjee SH, Winton TL, Van Nostrand P, Pearson FG. Adenoid cystic carcinoma of the airway: thirty-two year experience. J Thorac Cardiovasc Surg 1996;112(6):1522–31.
  • 25. Wo Y, Li S, Wang Y, Lu T, Qin Y, Sun X, et al. Predictors of nodal metastasis and prognostic significance of lymph node ratio and total lymph node count in tracheobronchial adenoid cystic carcinoma. Cancer Manag Res 2018;10:5919–25.
  • 26. Rostom AY, Morgan RL. Results of treating primary tumours of the trachea by irradiation. Thorax 1978;33(3):387–93.
  • 27. Makarewicz R, Mross M. Radiation therapy alone in the treatment of tumours of the trachea. Lung Cancer 1998;20(3):169–74.
  • 28. Fields JN, Rigaud G, Emami BN. Primary tumors of the trachea; Results of radiation therapy. Cancer 1989;63(12):2429–33.
  • 29. Mornex F, Coquard R, Danhier S, Maingon P, El Husseini G, Van Houtte P. Role of radiation therapy in the treatment of primary tracheal carcinoma. Int J Radiat Oncol Biol Phys 1998;41(2):299–305.
  • 30. Fuwa N, Ito Y, Matsumoto A, Morita K. The treatment results of 40 patients with localized endobronchial cancer with external beam irradiation and intraluminal irradiation using low dose rate (192) Ir thin wires with a new catheter. Radiother Oncol 2000;56(2):189–95.
  • 31. Harms W, Latz D, Becker H, Gagel B, Herth F, Wannenmacher M. Treatment of primary tracheal carcinoma. The role of external and endoluminal radiotherapy. Strahlenther Onkol 2000;176(1):22–7.
  • 32. Je HU, Song SY, Kim DK, Kim YH, Jeong SY, Back GM, et al. A 10-year clinical outcome of radiotherapy as an adjuvant or definitive treatment for primary tracheal adenoid cystic carcinoma. Radiat Oncol 2017;12(1):196.
  • 33. Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, Vogelius IS, et al. Radiation dose volume effects in the lung. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S70–6.
  • 34. Chang CY, Cheng SL, Chang SC. Adenoid cystic carcinoma of trachea treated with tumor curettage and adjuvant intensity modulated radiation therapy. South Med J 2011;104(1):68–70.
  • 35. Yathiraj PH, Ail S, Singh A, Mamidipudi V. Unresectable squamous cell carcinoma of upper trachea with long-term survival after concurrent chemoradiotherapy. BMJ Case Rep 2017;2017.pii:bcr-2017-221284.
  • 36. Joshi NP, Haresh KP, Das P, Kumar R, Prabhakar R, Sharma DN, et al. Unresectable basaloid squamous cell carcinoma of the trachea treated with concurrent chemoradiotherapy: a case report with review of literature. J Cancer Res Ther 2010;6(3):321–3.
  • 37. Videtic GM, Campbell C, Vincent MD. Primary chemoradiation as definitive treatment for unresectable cancer of the trachea. Can Respir J 2003;10(3):143–4.
  • 38. Tapias LF, Shih A, Mino-Kenudson M, Muniappan A, Gaissert HA, Lanuti M, et al. Programmed death ligand 1 and CD8+ immune cell infiltrates in resected primary tracheal malignnat neoplasms. Eur J Cardiothorac Surg 2019;55(4):691–8.
  • 39. Maller B, Kaszuba F, Tanvetyanon T. Complete tumor response of tracheal squamous cell carcinoma after treatment with pembrolizumab. Ann Thorac Surg 2019;107(4):e273–4.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.